Staci Gruber, Ph.D.

Quick facts

Phase 2 pipeline

• Full-Spectrum Cannabidiol · Neurology
  Cannabidiol acts as a CB1 receptor antagonist
• Single-Compound Cannabidiol

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Staci Gruber, Ph.D. portfolio CI brief
• Staci Gruber, Ph.D. pipeline updates RSS